Navigation Links
Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting

the 25 patients (36%) in the Phase I trial remain on study and are continuing to be treated with CB7630.

Dr. Arie S. Belldegrun, MD, FACS, Vice Chairman of the Board of Directors of Cougar Biotechnology, said, "The interim data on CB7630 presented at the ASCO Annual Meeting continues to support the role of the drug as both a second line hormonal therapy, as well as a second line chemotherapy. We are also pleased to be able to demonstrate that CB7630 is active in patients who have failed ketoconazole, a drug that is currently widely used off-label as a secondary hormonal therapy. As both addressable patient populations (second line hormone therapy candidates and second line chemotherapy candidates) continue to represent significant unmet medical needs in CRPC, we believe that CB7630 has strong potential in both of these patient populations." Alan H. Auerbach, Chief Executive Officer and President of Cougar Biotechnology, added, "We continue to be pleased with the interim clinical data being generated on CB7630. We greatly look forward to the continued development of CB7630 in both the second line hormone therapy and second line chemotherapy settings."

About Cougar Biotechnology

Cougar Biotechnology, Inc. is a Los Angeles-based biotechnology company established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar's oncology portfolio includes CB7630, a targeted inhibitor of the 17-alpha hydroxylase/c17,20 lyase enzyme, which is currently being tested in Phase II clinical trials in prostate cancer; CB3304, an inhibitor of microtubule dynamics, which is currently in a Phase I trial in hematological malignancies and CB1089, an analog of vitamin D, which has been clinically tested in a number of solid tumor types.

Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com.

This press release contains forward-looking statements within the meaning of the Pri
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
3. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
7. Prana Biotechnology Presents New Key Findings on PBT2
8. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:8/18/2008)...- Oramed,Pharmaceuticals, I...developer,of oral delivery systems, announced toda... Assess the Safety, Pharmacokinetics (PK) and,Phar...s in Healthy,Subjects," has been chosen for presen...European Association for the Study of Diabetes (EA...
(Date:8/17/2008)...nhua-- Pharmaxis,(ASX: PXS;...tal Phase 3,clinical trial of Bronchitol for the t...t., The first efficacy data from the trial is exp...9. The trial commenced its dosing phase in,April 2... subjects in June,2008 and closed today with 325 s...
(Date:8/14/2008)...BiTE) showing clinical benefit in cancer,patients;...gnize and attack canc...tCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a bioph...,antibodies for the treatment of cancer, inflammat...cation of a Phase 1 clinical study(1) on its,BiTE(...
(Date:8/13/2008)...irstCall/ -- As biotechnology,pharmaceutical and ...l,trials beyond their own borders to other parts o...h America, complicated regulatory environments,cha...ing to an analysis by,Aon Corporation (NYSE: AOC ...ose companies a visual representation of the compl...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4Healthcare M 26A Activity on the Rise 9649 1Healthcare M 26A Activity on the Rise 9649 2Internet Comes to Rescue of 14 Million Uninsured in U S 3B Providing Access to Gov Health Programs Theyre Not Aware of 9645 1Internet Comes to Rescue of 14 Million Uninsured in U S 3B Providing Access to Gov Health Programs Theyre Not Aware of 9645 2Internet Comes to Rescue of 14 Million Uninsured in U S 3B Providing Access to Gov Health Programs Theyre Not Aware of 9645 3New Poll 3A Only 16 25 of Californians Support Mandatory Purchase of Private Health Insurance 3B 71 25 Behind Regulation of Premium Increases 9641 1New Poll 3A Only 16 25 of Californians Support Mandatory Purchase of Private Health Insurance 3B 71 25 Behind Regulation of Premium Increases 9641 2Society for Biological Engineering Holds First International Conference on Stem Cell Engineering 2615 1Society for Biological Engineering Holds First International Conference on Stem Cell Engineering 2615 2
...ch 12, 2007: Progen Industries Limited,(ASX: PGL; ...8,Phase II liver cancer data has been accepted for...ssociation for the Study of the Liver,(EASL). Prog...er,cancer trial at the American Association for Ca...xpectation of having final data fully analysed and...
...d Safety Profile and Excellent,Pharmacokinetic Pro... 2007 /PRNewswire/ --,CeNeRx BioPharma, Inc., a cl...g innovative treatments for diseases of the centra... from a Phase I,clinical trial of Tyrima(TM), its ... anxiety. In this study, Tyrima was safe and well,...
Other Medicine Technology:PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:8/20/2008)...usetts General Hospital (MGH) investigators have f...em cell appeared to protect gastrointestinal tissu...ir report published in the journal Stem Cells , t...icine report that mesenchymal stem cells (MSCs), k...allowed the regeneration of the gastrointestinal l...
(Date:8/20/2008)...NGTON, Aug. 20 /PRNewswire-USNewswire/ -- Yesterda... admitted to Huron Hospital after,suffering an ane...Ohio. At,the present time Rep. Tubbs Jones, condit...are available., Tuesday,s condition followed a fu...ming forum on electoral reform, scheduled for Sept...
(Date:8/20/2008)... Micro(R) PUMP and ELLEgirl.com Send Four Girls to...Summer, LOS ANGELES, Aug. 20 /PRNewswire/ -- Reti...eenage Web site ELLEgirl.com to send four contest,...Camp in Santa Monica,California. With the new sch...mpower girls to become successful women by helping...
(Date:8/20/2008)...IEGO, Aug. 20 /PRNewswire/ --You,re late for work,...r car won,t start. How do you deal with,the rising...ash out in,frustration, how you deal with anger af...r children and even your career., As hard as we m...push,our buttons. While feeling anger isn,t a bad ...
Breaking Medicine News(10 mins):Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:Taming Your Temper: Learning to Turn Down the Heat 2
...oLipo(TM) laser module received clearance from the...ted lipolysis, and its BBL(TM) broadband pulsed li...les. ProLipo represents the latest technological ...ber-delivered laser energy to target fatty tissue....
... food for its 2.3 million soldiers, with the milit... recent spate of health scandals, state media rep...e or substandard food products and eliminating the... eating from the same plate, according to an annou...
...r a day, the Australian police finally announced t... in southern India, was being charged with provid...em a mobile phone SIM card. His cousin Sabeel Ahm... in Runcorn, southeast of Liverpool, has been accu...
... registry of pregnancies and abortions to stem sel... according to a report. India has only 927 femal...ldwide average of 1,050 females -- mainly due to s...e country where many people prefer to have male ch...
Other Medicine News:Health News:Sciton Receives FDA Clearance for Lipolysis and Wrinkle Treatment 2Health News:Three Doctors Charged So Far in the UK Bombing Case 2Health News:Three Doctors Charged So Far in the UK Bombing Case 3Health News:Three Doctors Charged So Far in the UK Bombing Case 4Health News:India to Monitor Pregnancies to Check Girl Foeticide: Report 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: